Table 1.
|
Acute aggressive |
Subacute mild |
Chronic indolent |
Presentation | Acute (< 10 d) | Subacute (< 2-4 wk) | Chronic (> 4 wk) |
Symptoms | Severe symptoms (RUQ pain, fever, toxicity, abdominal distention, leg edema, shock-like syndrome resembling sepsis, jaundice, signs of intraperitoneal or intrathoracic rupture) | Moderate symptoms(usually intermittent fever and RUQ tenderness) | Mild (usually RUQ tenderness, fever if secondary infection) |
Laboratory tests | Marked leukocytosis (> 20000/μL), abnormal LFT, features of organ failure (hyperbilirubinemia, renal dysfunction) | Transient leukocytosis and transient elevation of LFT (returns to normal after treatment) | Usually normal |
Imaging features | Incomplete or absent wall, ragged edge, interrupted or no enhancement, septations, heterogeneous content, widespread or wedge-shaped perilesional hypodensity | Relatively smooth outline, rim-enhancing wall with perilesional hypodense “halo” (double-target sign) | Smooth outline, thick non-enhancing wall, faint or no perilesional “halo” |
Size and number | > 5-10 cm, multiple in over 50% of cases | < 5-10 cm, usually single | > 5-10 cm, usually single |
Treatment | Antibiotics; Early drainage is often required to control severity | Antibiotic alone suffices in most cases; rapid recovery, drainage when symptoms persist | Mostly pre-treated with antibiotics, drainage not required unless pressure symptoms or secondary infection present |
RUQ: Right upper quadrant; LFT: Liver function test.